Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Odor Identification Ability Predicts PET Amyloid Status and Memory Decline inĀ Older Adults.

Kreisl WC, Jin P, Lee S, Dayan ER, Vallabhajosula S, Pelton G, Luchsinger JA, Pradhaban G, Devanand DP.

J Alzheimers Dis. 2018;62(4):1759-1766. doi: 10.3233/JAD-170960.

2.

Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.

Lan MJ, Ogden RT, Kumar D, Stern Y, Parsey RV, Pelton GH, Rubin-Falcone H, Pradhaban G, Zanderigo F, Miller JM, Mann JJ, Devanand DP.

J Alzheimers Dis. 2017;60(3):939-947. doi: 10.3233/JAD-161284.

3.

Antibacterial effects of silver-zirconia composite coatings using pulsed laser deposition onto 316L SS for bio implants.

Pradhaban G, Kaliaraj GS, Vishwakarma V.

Prog Biomater. 2014 Dec;3(2-4):123-130. doi: 10.1007/s40204-014-0028-5. Epub 2014 Nov 14.

4.

MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.

Devanand DP, Bansal R, Liu J, Hao X, Pradhaban G, Peterson BS.

Neuroimage. 2012 Apr 15;60(3):1622-9. doi: 10.1016/j.neuroimage.2012.01.075. Epub 2012 Jan 25.

5.

Hydrocortisone responsiveness in Gulf War veterans with PTSD: effects on ACTH, declarative memory hippocampal [(18)F]FDG uptake on PET.

Yehuda R, Golier JA, Bierer LM, Mikhno A, Pratchett LC, Burton CL, Makotkine I, Devanand DP, Pradhaban G, Harvey PD, Mann JJ.

Psychiatry Res. 2010 Nov 30;184(2):117-27. doi: 10.1016/j.pscychresns.2010.06.010. Epub 2010 Oct 8.

PMID:
20934312
6.

(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease.

Devanand DP, Van Heertum RL, Kegeles LS, Liu X, Jin ZH, Pradhaban G, Rusinek H, Pratap M, Pelton GH, Prohovnik I, Stern Y, Mann JJ, Parsey R.

Am J Geriatr Psychiatry. 2010 Nov;18(11):959-72. doi: 10.1097/JGP.0b013e3181ec8696.

7.

Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls.

Devanand DP, Mikhno A, Pelton GH, Cuasay K, Pradhaban G, Dileep Kumar JS, Upton N, Lai R, Gunn RN, Libri V, Liu X, van Heertum R, Mann JJ, Parsey RV.

J Geriatr Psychiatry Neurol. 2010 Sep;23(3):185-98. doi: 10.1177/0891988710363715. Epub 2010 Apr 29.

8.

Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.

Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH.

Biol Psychiatry. 2008 Nov 15;64(10):871-9. doi: 10.1016/j.biopsych.2008.06.020. Epub 2008 Aug 23.

9.

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ.

Neurology. 2007 Mar 13;68(11):828-36.

PMID:
17353470

Supplemental Content

Loading ...
Support Center